Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
H2NVAC Vaccine for Breast Cancer
Recruiting1 awardPhase 1
Rochester, Minnesota
This trial is testing a new vaccine for patients with HER2 expressing ductal carcinoma in situ. The vaccine is designed to stimulate white blood cells in hopes of increasing immune response and protecting against breast cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.